PSA Testing & Prostate Cancer Screening
Prostate cancer screening plays an important role in identifying potential signs of prostate cancer before symptoms develop. One of the most commonly used screening methods is the Prostate-Specific Antigen (PSA) blood test. Understanding PSA levels, screening options and follow-up investigations can help men make informed decisions about their prostate health.

Dr. Ashwin Tamhankar, a urological oncologist and robotic surgeon, provides specialised care for prostate cancer, including early detection, diagnosis and personalised treatment planning.

What Is PSA Testing?

PSA testing is a blood test that measures the level of prostate-specific antigen (PSA), a protein produced mainly by the prostate gland. Small amounts of PSA are normally present in the blood.

Elevated PSA levels may indicate prostate cancer, but they can also occur due to non-cancerous conditions such as benign prostatic hyperplasia (BPH), prostate inflammation or infection.

A PSA test alone cannot confirm or rule out prostate cancer. Doctors interpret the result alongside the patient's age, medical history, symptoms, family history and other clinical findings.

Why Is Prostate Cancer Screening Important?

Prostate cancer is a significant health concern among men, particularly as they grow older. In its early stages, it may not cause noticeable symptoms. Screening can help identify men who may benefit from further evaluation.

Potential benefits of appropriate prostate cancer screening include:

Identifying abnormal PSA levels before symptoms appear.

Helping assess the need for further diagnostic investigations.

Supporting early diagnosis in selected patients.

Enabling informed discussions about treatment and monitoring options.

Assessing prostate health in men with a family history of prostate cancer.

Screening has limitations, including false-positive results and the detection of cancers that may never cause significant health problems. Therefore, the decision to undergo PSA testing should be individualised.

Who Should Consider PSA Testing?

The decision to undergo prostate cancer screening depends on several factors, including age, family history, overall health and personal preferences.

Men who may benefit from discussing PSA testing with a specialist include:

Men aged 50 and above: Discuss screening based on individual risk and overall health.

Men with a family history of prostate cancer: A father or brother with prostate cancer may increase personal risk, especially when diagnosed at a younger age.

Men with inherited cancer-risk factors: Certain genetic variants, including BRCA2, can increase prostate cancer risk.

Men experiencing urinary symptoms: Difficulty urinating, a weak urine stream or frequent urination may require evaluation, although these symptoms do not necessarily indicate cancer.

Men with previously elevated PSA levels: Further assessment may be appropriate depending on the result and clinical history.

Men at increased risk may need to discuss screening at an earlier age. There is no single screening schedule suitable for everyone.

PSA Testing vs. Prostate Cancer Diagnosis

PSA testing is a screening and risk-assessment tool, not a definitive diagnostic test.

Screening aims to identify people who may need further evaluation. Diagnosis involves additional investigations, which may include MRI and a prostate biopsy.

If prostate cancer is confirmed, further assessment determines its grade, stage and risk category. These findings help the specialist recommend an appropriate treatment or monitoring plan.

For professional guidance on PSA testing, prostate cancer screening, diagnosis and treatment, consult Dr. Ashwin Tamhankar, a urological oncologist and robotic surgeon.
Call us on 08048035182
Oct 27th, 2026 3:36 PM

Keywords